FOLFIRINOX Equals Gemcitabine-Based Chemoradiotherapy for Pancreatic Cancer
Neoadjuvant FOLFIRINOX and gemcitabine-based chemoradiotherapy were comparably effective for pancreatic cancer.
Read More
Author: Teresa Sellinger
Erdafitinib Similar to Pembrolizumab for Urothelial Cancer
Erdafitinib did not outperform pembrolizumab as second-line treatment for metastatic urothelial carcinoma.
Read More
Short Induction Chemo Improves Survival in Advanced Cervical Cancer
Carboplatin/paclitaxel induction chemotherapy, directly followed by standard chemoradiotherapy, improved survival in locally advanced cervical cancer.
Read More
First Effective First-Line Chemo/Immunotherapy Combo for Urothelial Cancer
Nivolumab plus chemotherapy is the first combination to outperform chemotherapy alone as first-line treatment for unresectable or metastatic urothelial cancer.
Read More
Superior PFS With Sotorasib in Colorectal Cancer
Patients with KRAS (G12C)-mutated, metastatic colorectal cancer (CRC) benefit from combination sotorasib and panitumumab
Read More
“LAG Time” Promising First-Line Treatment for Metastatic NSCLC
Soluble LAG-3 protein eftilagimod alpha combined with pembrolizumab shows promising clinical efficacy as first-line treatment for advanced or metastatic NSCLC.
Read More
Innovative & Insightful IBS-C Peer to Peer eBook
An innovative, curated ebook featuring insightful IBS-C findings and input from key opinion leaders in the field of gastroenterology.
Read More
Q&A: Collaboration Improves PrEP Uptake in Latino MSM
Collaboration among healthcare providers and community-based organizations may be a viable strategy to increase PrEP uptake among Latino MSM.
Read More
Q&A: Availability of Multiple Options for NSCLC is “Very Exciting”
Selecting a treatment for operable non-small cell lung cancer from the many options available involves consideration of tumor stage and biomarkers.
Read More
Primary Care Intervention Aids Patient Follow-Up for Abnormal Cancer Screening
Primary care clinicians take a “whole person” approach and are responsible for a wide range of preventive healthcare efforts.
Read More
Healthcare Organizations Can Do More for Women Leaders in Academic Medicine
Women are underrepresented in leadership positions in a wide range of industries, and medicine is no exception. Healthcare organizations can do more for women.
Read More
Addressing New Challenges in Medical Education
Medical education faces challenges that affect the quality of training and the preparedness of future healthcare workforce.
Read More
In Patients With HIV, Non-Alcoholic Fatty Liver Disease Increases Cardiovascular Risk
Patients with HIV and NAFLD experience a greater risk for adverse cardiovascular outcomes than those with HIV alone.
Read More
Functional MRI Identifies Changes in Cerebral Regional Homogeneity Among Patients With TD
Resting-state functional MRI results show that patients with schizophrenia and tardive dyskinesia have altered cerebral regional homogeneity.
Read More
Selpercatinib Doubles Progression-Free Survival in RET-Mutated NSCLC
Selpercatinib doubled progression-free survival, increased response rate, and delayed pulmonary and physical deterioration in RET fusion-positive NSCLC.
Read More
No Surgery After Neoadjuvant Chemoradiotherapy in Esophageal Cancer?
Active surveillance after neoadjuvant chemoradiotherapy may be an alternative to surgery for some with esophageal cancer.
Read More
Toripalimab/Chemotherapy Combo Improves Outcomes in Small Cell Lung Cancer
Toripalimab added to etoposide plus cisplatin or carboplatin improved survival in extensive-stage small cell lung cancer.
Read More
Addition of Pembrolizumab Improves pCR in Patients With Early-Stage High-Risk ER+/HER2- Breast Cancer
Pembrolizumab plus neoadjuvant chemotherapy in early-stage, high-risk ER+/HER2- breast cancer leads to a statistically significant increase in pathological complete response.
Read More
NICHE-3 Demonstrates Equally Impressive Results as NICHE-2
Nivolumab/relatlimab neoadjuvant treatment of deficient mismatch repair colon cancer shows impressive pathological response rates.
Read More